Gangwon Creative Economy Innovation Center (CEO Lee Hae-jeong, hereinafter referred to as Gangwon Innovation Center) announced on the 11th that it signed a business agreement (MOU) with Jetema Co., Ltd. (CEO Kim Jae-young, Nam Jeong-seon) and will be fully operating an open innovation program. The agreement ceremony was held on that day in the conference room of Jetema Global Pangyo R&D Center.
On this day, the signing ceremony was attended by officials including Lee Hae-jeong, CEO of Gangwon Innovation Center, and Nam Jeong-seon, CEO of Jetema, and discussed ways to activate the bio industry ecosystem and promote open innovation programs.
Jetema, headquartered in Wonju, is an aesthetics company listed on KOSDAQ in 2019, selling products such as hyaluronic acid fillers and botulinum toxin domestically and internationally. Jetema plans to strengthen the competitiveness of its main business by discovering startups with excellent technology and service capabilities that have the potential for strategic collaboration through open innovation with the Gangwon Innovation Center, and actively secure next-generation innovative technologies and items. The Gangwon Innovation Center plans to operate an open innovation program through an agreement with Jetema and support promising startups through infrastructure and personnel exchanges.
Lee Hae-jeong, the head of Gangwon Innovation Center, said, “Through this agreement and open innovation program, we will actively contribute to strengthening the competitiveness of the bio-aesthetics industry ecosystem and startups in the Gangwon region,” and Nam Jeong-seon, the CEO of Jetema, emphasized, “Through cooperation with Gangwon Innovation Center, we will discover startups with potential and utilize Jetema’s innovation capabilities to open up new possibilities for the future bio-aesthetics industry together.”
- See more related articles
You must be logged in to post a comment.